Profil
David Roger Lloyd was an Executive Director of Global Licensing at AstraZeneca PLC.
He was also a Non-Executive Director at Alizyme Plc and a Principal at Zeneca Garden Care.
From 2015 to 2018, he served as an Independent Non-Executive Director at Genedrive Plc.
Anciens postes connus de David Roger Lloyd
Sociétés | Poste | Fin |
---|---|---|
GENEDRIVE PLC | Directeur/Membre du Conseil | 31/12/2018 |
Zeneca Garden Care
Zeneca Garden Care Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million. | Corporate Officer/Principal | - |
ASTRAZENECA PLC | Corporate Officer/Principal | - |
Alizyme Plc
Alizyme Plc Pharmaceuticals: MajorHealth Technology Alizyme Plc was engaged in the development of pharmaceutical products for the diseases related to obesity treatment. The company was founded in 1995 and was headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
GENEDRIVE PLC | Health Technology |
ASTRAZENECA PLC | Health Technology |
Entreprise privées | 2 |
---|---|
Alizyme Plc
Alizyme Plc Pharmaceuticals: MajorHealth Technology Alizyme Plc was engaged in the development of pharmaceutical products for the diseases related to obesity treatment. The company was founded in 1995 and was headquartered in Cambridge, the United Kingdom. | Health Technology |
Zeneca Garden Care
Zeneca Garden Care Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million. | Health Technology |